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Introduction
The Wnt family of secreted glycoproteins plays a critical role 
in developmental processes including axis patterning, cellular 
proliferation, planar cell polarity, cell migration, cell fate speci-
fication, and neuronal development. In adults, Wnt signaling is 
involved in tissue homeostasis, regeneration, and stem/progeni-
tor cell function. Moreover, elevated or attenuated Wnt signal-
ing is found in a diversity of diseased tissues (Logan and Nusse, 
2004; Moon et al., 2004).
Wnt signaling can be divided into CTNNB1-dependent 
and CTNNB1-independent signaling. The best-characterized 
family of receptors for Wnts is the Frizzled class of seven-pass 
transmembrane atypical G protein–coupled receptors. In addi-
tion, CTNNB1-dependent signaling requires a coreceptor, the 
low-density lipoprotein receptor–related proteins 5 and 6 (LRP). 
More recently, it has become clear that two additional un-
related, single-pass receptor tyrosine kinases, receptor tyro-
sine kinase-like orphan receptor 2 (ROR2) and receptor-like 
tyrosine  kinase  (RYK),  can  bind  to  Wnts.  In  contrast  to   
signaling  events  downstream  of  the  Frizzled/LRP  receptors,   
the mechanisms of ROR2- and RYK-mediated Wnt signaling 
are poorly understood (Angers and Moon, 2009). RYK has 
been shown to bind to Frizzleds (Lu et al., 2004; Kim et al., 
2008; Li et al., 2009). However, Frizzleds are not required 
for Wnt/RYK signaling in all contexts (Inoue et al., 2004; 
Schmitt et al., 2006; Harris and Beckendorf, 2007; Li et al., 
2009),  which  suggests  a  distinct  molecular  mechanism  of 
Wnt/RYK signaling.
RYK is required for CTNNB1-dependent Wnt signaling, 
as loss of function of RYK inhibits the ability of Wnt-3A to   
activate  a  CTNNB1-dependent  transcriptional  reporter  in   
human embryonic kidney (HEK293T) cells (Lu et al., 2004). 
Moreover,  RYK  is  required  for  Wnt/CTNNB1  signaling   
in vivo. In the specification of vulva cell fate in Caenorhabditis 
elegans, LIN-18/RYK shows a genetic interaction with WNT/
MOM-2 and TCF/POP-1 (Inoue et al., 2004; Deshpande et al., 
2005). In mice, RYK is required for Wnt-3A–induced neurite 
outgrowth from explanted dorsal root ganglia (Lu et al., 2004) 
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transmembrane receptor for the Wnt family of se-
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endocytosis in response to Wnt, the mechanisms that regu-
late its internalization and concomitant activation of Wnt 
signaling  are  unknown.  We  discovered  that  RYK  both 
physically and functionally interacts with the E3 ubiquitin 
ligase Mindbomb 1 (MIB1). Overexpression of MIB1 pro-
motes the ubiquitination of RYK and reduces its steady-
state levels at the plasma membrane. Moreover, we show 
that MIB1 is sufficient to activate Wnt/-catenin (CTNNB1) 
signaling and that this activity depends on endogenous 
RYK. Conversely, in loss-of-function studies, both RYK and 
MIB1  are  required  for  Wnt-3A–mediated  activation  of 
CTNNB1. Finally, we identify the Caenorhabditis elegans 
orthologue of MIB1 and demonstrate a genetic interaction 
between  ceMIB  and  lin-18/RYK  in  vulva  development. 
These findings provide insights into the mechanisms of 
Wnt/RYK  signaling  and  point  to  novel  targets  for  the 
modulation of Wnt signaling.
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(Lu et al., 2004). We isolated glue-tagged RYK from cells 
that were treated and lysed under several conditions to iden-
tify the maximum number of interaction partners (Table S3).   
Because RYK is known to be cleaved and internalized, we 
also performed affinity purification of glue-tagged RYKICD 
from stably expressing HEK293T cells. Using this combined 
approach, we identified several known RYK-interacting pro-
teins including CDC37, ubiquitin, HSP90, and ephrin recep-
tors (Fig. 1 A and Table S3; Halford et al., 2000; Trivier 
and Ganesan, 2002; Kamitori et al., 2005; Lyu et al., 2009).
 We identified a total of 66 RYK-associated proteins that 
met the following criteria: (a) the proteins were identified in 
at least three of eight independent pull-down experiments,   
(b) the proteins were represented by at least two unique pep-
tides, and (c) the proteins had not been previously identified 
as common nonspecific contaminants (Gingras et al., 2005; 
Major et al., 2008).
Using bioinformatic analyses, we classified these proteins 
into several complexes or families of proteins involved in cell 
signaling, cell adhesion, cell cycle and apoptosis, actin remod-
eling, planar cell polarity, ubiquitination, and protein trafficking 
(Fig. 1 A and Table S4). Among the novel proteins identified, 
the most frequently observed and the highest in abundance was 
the E3 ubiquitin ligase MIB1.
RYK exists in a protein complex with MIB1
To confirm the finding that RYK and MIB1 coexist in a pro-
tein complex, we used affinity purification and Western blot-
ting.  We  found  that  streptavidin  purification  of  glue-tagged 
RYK, RYKICD, or of a plasma-membrane tethered, i.e., myris-
toylated, version of the RYKICD (MYR-RYKICD) efficiently 
coprecipitated endogenous MIB1 as compared with untrans-
fected HEK293T cells or those expressing glue-tagged nega-
tive control proteins (Fig. 1, B and C). Moreover, in the reverse 
pull-down experiment, flag-tagged MIB1 coprecipitated glue-
RYKICD (Fig. 1 D).
Previous  studies  have  shown  that  substrates  of  MIB1-
mediated ubiquitination bind to its N-terminal MIB/HERC2-
type zinc finger (Itoh et al., 2003). Therefore, we performed an 
analysis to define the domain of MIB1 required for forming a 
complex with RYK. We transiently expressed a series of flag-
tagged N- and C-terminal truncations of MIB1 in cells stably 
transfected with glue-RYKICD. We found that the RYKICD 
efficiently coprecipitated with the N terminus of MIB1 (mini-
mal binding domain aa 1–124) but not the C terminus (Fig. 1,   
B and D). We also observed that RYK could form a complex 
with a point mutant of MIB1 (C997S) that reduces its enzy-
matic activity (Fig. 1 D). In summary, these results show that 
RYK and MIB1 exist in a protein complex in a manner requir-
ing the interaction of the ICD of RYK and the substrate recogni-
tion domain of MIB1.
MIB1 promotes the ubiquitination of RYK
MIB1 acts as an E3 ubiquitin ligase for several substrates (Jin 
et al., 2002; Itoh et al., 2003; Yoo et al., 2006; Zhang et al., 
2007). Thus, we investigated whether MIB1 could promote 
the  ubiquitination  of  RYK.  We  performed  nickel  affinity   
and  neuronal  differentiation  of  neocortical  progenitor  cells 
(Lyu et al., 2008).
RYK is also involved in stimulating CTNNB1-independent   
Wnt signaling pathways. Genetic and biochemical studies 
demonstrate that Wnt-5 and RYK cooperate to regulate axon 
pathfinding in vivo and in vitro in multiple species (Liu et al., 
2005; Keeble et al., 2006; Wouda et al., 2008; Li et al., 2009; 
Miyashita et al., 2009). Moreover, Wnt-5 and Wnt-11 signal 
through RYK to regulate cell movements during convergent 
extension of zebrafish (Danio rerio) and frog (Xenopus laevis)   
embryos (Kim et al., 2008; Lin et al., 2010). Though not   
directly tested in these studies, Wnt-5 and Wnt-11 have been 
reported  to  signal  independently  of  CTNNB1  in  a  context- 
dependent manner.
The  molecular  mechanisms  of  Wnt/RYK  signaling   
remain elusive. RYK is composed of a leucine-rich extracel-
lular domain with a WIF-type Wnt binding region, a single 
transmembrane domain, and an intracellular tyrosine kinase 
domain  (Halford  and  Stacker,  2001).  Most  evidence  sug-
gests that RYK signaling does not depend on intrinsic kinase   
activity;  however,  RYK  has  been  shown  to  interact  with 
other kinases including Ephrin receptors and Src, which sug-
gests cross-talk with other tyrosine kinase signaling cascades   
(Halford et al., 2000; Trivier and Ganesan, 2002; Kamitori   
et al., 2005; Wouda et al., 2008). In addition, in neuronal pre-
cursor cells, RYK is cleaved by -secretase, and treatment with   
Wnt-3A leads to the nuclear accumulation of the RYK intra-
cellular domain (RYKICD; Lyu et al., 2008). Whether the 
RYKICD binds to DNA or has any role in the regulation of 
transcription remains an open question. Finally, two recent 
studies show that RYK is internalized in response to Wnt-5 
and Wnt-11 (Kim et al., 2008; Lin et al., 2010). However, nei-
ther the consequences of RYK internalization nor the factors 
that regulate internalization are known.
In this paper, we identified RYK-associated proteins by 
affinity purification mass spectrometry and leveraged the re-
sults  to  investigate  the  mechanisms  of  Wnt/RYK  signaling.   
Although this approach identified multiple proteins that co-
purify with RYK, in this study we focused on the E3 ubiquitin   
ligase  MIB1.  Biochemical  experiments  revealed  that  MIB1 
promotes the ubiquitination and turnover of full-length RYK 
and results in the loss of RYK expression at the cell surface. 
Moreover, using both gain- and loss-of-function experiments in 
vitro and in vivo, we found an as of yet unreported functional 
relationship between RYK and MIB1 in the positive regulation 
of Wnt/CTNNB1 signaling.
Results
Affinity purification mass spectrometry  
of RYK
To identify proteins that were candidates for mediating Wnt/
RYK signaling, we used tandem affinity purification of RYK 
followed by mass spectrometry (Angers et al., 2006; Major   
et al., 2007). We stably expressed glue-tagged RYK at low levels 
in HEK293T cells, which have intact Wnt/RYK signaling 739 MIB1 is required for Wnt/RYK signaling • Berndt et al.
ubiquitin to other substrates (Jin et al., 2002; Itoh et al., 2003; 
Yoo et al., 2006; Zhang et al., 2007). Similarly, we found that 
MIB1 with a point mutation (C997S) in the third ring domain 
or  MIB1  lacking  all  three  ring  domains  (aa  1–729;  MIB1-
RN3)  significantly  reduced  or  eliminated,  respectively,  the 
ability of MIB1 to promote the ubiquitination of RYK (Fig. 2 A). 
purification  of  urea-denatured  HEK293T  cell  lysates  trans-
fected with 6XHIS-ubiquitin, glue-RYK, and flag-MIB1. We 
found that MIB1 overexpression dramatically increased the 
level of ubiquitination of RYK (Fig. 2 A). Amino acid sub-
stitutions or deletions in the C-terminal enzymatic ring domains   
of MIB1 have been shown to impair its ability to conjugate 
Figure 1.  Affinity purification mass spectrometry identifies MIB1 as a novel interaction partner with RYK. (A) Illustration depicts the RYK-associated protein 
interaction network discovered by affinity purification mass spectrometry (black lines). The STRING database was used to curate additional interactions 
among proteins found to interact with RYK (gray lines). The size of the node indicates the total number of peptides identified in eight independent purifica-
tions. (B) Schematic representation of RYK and MIB1 proteins depicting predicted domains. (C) Western blot for endogenous MIB1 demonstrates interaction 
with streptavidin affinity-purified glue-tagged RYK, RYKICD, or a membrane tethered form of the RYKICD (MYR-RYKICD). Untransfected, glue-TCF4, and 
glue-NCK2 cells served as negative controls. (D) Western blot for glue-RYKICD demonstrates interactions with flag affinity-purified full-length MIB1, the 
N terminus of MIB1, or a point mutant (C997S) of MIB1 that renders it catalytically impaired. N-terminally truncated MIB1 and negative controls do not 
copurify RYK. Blots represent n > 3.JCB • VOLUME 194 • NUMBER 5 • 2011   740
immunoreactivity of streptavidin affinity-purified glue-RYKICD 
(Fig. 2 B). In addition, a point mutation in MIB1 (S807A) that 
inhibits  phosphorylation  by  PAR1  and  subsequent  auto-
ubiquitination (Ossipova et al., 2009) did not interfere with the 
ubiquitination of RYK (Fig. 2 B). Thus, MIB1 is sufficient to 
promote the ubiquitination of RYK in the absence of exoge-
nous ubiquitin.
Mouse Ryk (mRYK) shares 93% amino acid identity 
with human RYK and 98% identity within the ICD, includ-
ing 18 of 19 lysines. mRYK is cleaved by -secretase and the 
In  addition,  we  found  that  MIB1  could  efficiently  promote   
the ubiquitination of glue-tagged RYKICD or MYR-RYKICD 
but not RYKICD, which lacks the ICD, (Fig. 2 A); this sug-
gests that MIB1 acts on the cytoplasmic tail of RYK. There-
fore, MIB1 is sufficient to promote the covalent addition of 
ubiquitin to RYK in a manner that depends on the intrinsic enzy-
matic activity of MIB1.
We next investigated whether MIB1 could enhance the 
conjugation of endogenous ubiquitin to RYK. Cells transfected 
with MIB1 but not MIB1-C997S robustly increased the ubiquitin 
Figure 2.  MIB1 promotes RYK ubiquitination. (A) Western blot analyzing metal-affinity purification of His-tagged ubiquitin under denaturing conditions. 
The blot shows that that MIB1 can promote the ubiquitination of the N-terminal glue-tagged RYK, RYKICD, and membrane-tethered MYR-RYKICD but not 
RYK lacking the ICD (RYKICD). Mutant MIB1, C997S, and truncated MIB1, RN3, have little or no catalytic activity with respect to RYK. (B) Western blot 
analyzing streptavidin purification of glue-RYKICD. The blot shows the conjugation of endogenous ubiquitin promoted by MIB1 and by nonphosphorylat-
able MIB1-S807A, but not by MIB1-C997S. (C) Western blot analyzing metal affinity purification of His-tagged ubiquitin under denaturing conditions 
showing that MIB1 can promote the ubiquitination of C-terminal myc-tagged mouse RYK, RYKICD, and noncleavable RYK-RC. Blots represent n > 3. The 
asterisk indicates a nonspecific band.741 MIB1 is required for Wnt/RYK signaling • Berndt et al.
glue-RYKICD  nor  the  plasma  membrane–tethred  form,   
MYR-glue-RYKICD, were significantly decreased by over-
expression  of  MIB1  (Fig.  3  A).  We  also  tested  whether   
C-terminal myc-tagged mRYK levels were affected by MIB1. 
Consistent with our results with human RYK, overexpression 
of MIB1 decreased the levels of full-length mRYK-myc but not 
of mRYK-ICD-myc (Fig. 3 B). Thus, MIB1 can promote the 
turnover of full-length RYK but not the RYKICD. We also dis-
covered that the levels of mRYK-RC-myc were decreased by 
MIB1 (Fig. 3 B). This result suggested that -secretase cleavage 
is not required for the ability of MIB1 to degrade RYK. Indeed, 
in a direct test of this hypothesis we found that MIB1 was able 
to degrade wild-type full-length mRYK-myc in the presence of 
either of two small molecule inhibitors of -secretase activity 
(Fig. 3 C). Collectively, these data demonstrate that the extra-
cellular region of RYK is required for efficient turnover and   
imply the presence of additional regulatory factors.
We next tested whether the inhibition of the proteasome 
or lysosome could restore RYK levels in the presence of over-
expressed MIB1. We found that addition of either MG132 or 
chloroquine, small molecule inhibitors of the proteasome and 
lysosome, respectively, resulted in increased steady-state levels   
ICD cleavage product has been shown to be ubiquitinated and 
degraded in the proteasome (Lyu et al., 2009). Therefore, we 
asked whether MIB1 could ubiquitinate mRYK by express-
ing  C-terminally  myc-tagged  mRYK  in  combination  with 
6XHIS-ubiquitin and human flag-MIB1. Similar to our results   
with human RYK, we found that MIB1 could efficiently ubiq-
uitinate mRYK and mRYKICD. In addition, we found that 
MIB1  could  ubiquitinate  mRYK-RC,  a  form  of  full-length 
mRYK that is resistant to -secretase cleavage (Fig. 2 C; Lyu 
et al., 2009). These results demonstrate that MIB1-mediated 
ubiquitination of RYK is not species-specific nor an artifact   
of the type or position of the epitope tag. Moreover, ubiqui-
tination by MIB1 does not depend on -secretase–mediated 
cleavage of RYK. In summary, our results with human and 
mouse RYK indicate that MIB1 is sufficient to promote the 
ubiquitination of RYK.
MIB1 promotes the turnover of RYK
We next tested the hypothesis that MIB1 overexpression de-
creases RYK protein levels. We found that the steady-state 
levels of full-length glue-RYK were decreased by MIB1 in   
a  dose-dependent  manner  (Fig.  3 A).  In  contrast,  neither   
Figure 3.  MIB1 promotes RYK protein turnover. (A) Western blot of cell lysates showing that MIB1 cDNA overexpression results in a decrease in full-length 
RYK but not RYKICD or MYR-RYKICD. (B) Western blot of cell lysates showing that MIB1 cDNA overexpression results in a decrease in full-length mouse 
RYK and noncleavable RYK-RC but not mouse RYKICD. (C) Western blot of cell lysates showing that MIB1 cDNA overexpression results in a decrease in 
full-length mouse RYK in the presence of -secretase inhibitors. (D) Western blot of cell lysates showing that MIB1-dependent degradation of RYK can be 
reversed by inhibition of the proteasome with MG132 or inhibition of the lysosome with chloroquine. (E) Western blot of cell lysates demonstrating that 
the inhibition of the expression of TSG101, a member of the ESCRT pathway, reverses the ability of MIB1 to degrade RYK. (F) Western blot of cell lysates 
demonstrating that the turnover of full-length RYK in the presence of translation inhibition by cycloheximide can be reversed with proteasome or lysosome 
inhibition. (G) Western blot of cell lysates demonstrating that the turnover of full-length RYK in the presence of cycloheximide can be reversed by knockdown 
of MIB1 with siRNAs. Blots represent n = 3.JCB • VOLUME 194 • NUMBER 5 • 2011   742
within 2 h of cycloheximide treatment (Fig. 3 F). Moreover, we 
found that we could delay the rate of RYK turnover by simultane-
ously treating cells with proteasome or lysosome inhibitors consis-
tent with ongoing RYK turnover by these organelles (Fig. 3 F).
Next, we transfected cells with control or MIB1 siRNAs 
and evaluated RYK turnover. Importantly, we found that the 
degradation of RYK in cycloheximide-treated cells was delayed 
by MIB1 loss of function (Fig. 3 G). These results support a 
model in which endogenous MIB1 promotes the turnover of 
full-length RYK through ubiquitination and degradation.
MIB1 colocalizes with RYK on Rab5-positive 
intracellular membranes
We also investigated the subcellular localization of RYK and 
MIB1. When glue-RYK was expressed in either HEK293T or 
Hela cells, it localized to the plasma membrane and intracellular 
of glue-RYK and inhibited the ability of MIB1 to degrade glue-
RYK (Fig. 3 D). Trafficking of ubiquitinated cargo to the lyso-
some depends on members of the ESCRT pathway, such as   
TSG101 (Raiborg and Stenmark, 2009). Therefore, to further test 
whether MIB1 overexpression leads to lysosomal degradation of 
RYK, we assessed levels of glue-RYK in the context of TSG101 
inhibition by siRNA. We found that TSG101 siRNA transfec-
tion  increased  steady-state  levels  of  RYK  and  inhibited  the 
ability of MIB1 to degrade RYK (Fig. 3 E). Collectively these 
results show that MIB1 overexpression is sufficient to promote 
the degradation of RYK by the proteasome and the lysosome.
The findings in Fig. 3 imply that endogenous MIB1 could 
regulate the rate of RYK turnover. To test whether endogenous 
MIB1 is required for RYK degradation, we first monitored the ex-
pression of full-length glue-RYK after inhibition of protein trans-
lation with cycloheximide. We found that RYK levels decreased 
Figure 4.  MIB1 colocalizes with RYK on intracellular membranes. (A–D) Single-plane confocal images of immunofluorescent labeling of HEK293T cells 
transiently transfected with cDNA encoding full-length glue-tagged RYK and flag-tagged MIB1 or variants of MIB1. RYK is primarily localized to the plasma 
membrane when expressed alone (A). However, when overexpressed with MIB1 (B), RYK and MIB1 colocalize to intracellular membranous organelles 
that are also positive for Rab5. Catalytically impaired MIB1-C997S colocalizes with RYK in aggregates at or near the plasma-membrane (C). In contrast, 
overexpression of MIB1 lacking all three enzymatic domains MIB1-RN3 (D) minimally affects RYK surface localization and colocalizes at the sites of cell 
protrusions. (E) Quantification of immunocytochemistry demonstrating that MIB1 and MIB1-C997S reduce the distribution of RYK along the plasma mem-
brane. Data are mean + SEM (error bars). *, P < 0.005 (Student’s t test, n = 4). Bar, 10 µm.743 MIB1 is required for Wnt/RYK signaling • Berndt et al.
Wnt/-catenin–activated luciferase reporter [BAR]; Biechele 
et al., 2009) in HEK293T cells after transfection of siRNAs 
against RYK or MIB1. Consistent with previously published 
data (Lu et al., 2004), we found that three independent siRNAs 
targeting RYK (Fig. S1, A and C) inhibited Wnt-3A–dependent 
activation of BAR by >50% (Fig. 6 A). Importantly, we also 
found that three independent siRNAs targeting MIB1 (Fig. S1, 
B and D) inhibited activation of BAR by Wnt-3A to a similar 
degree as RYK siRNAs (Fig. 6 A).
In addition, we investigated whether RYK and MIB1 loss 
of function could reduce the expression of endogenous Wnt/
CTNNB1 target genes. We found that treating HEK293T cells 
with Wnt-3A induced a modest increase in the levels of AXIN2 
that could be partially reversed by MIB1 or RYK loss of func-
tion (Fig. 6 B). Unpublished results from our laboratory show 
that the osteosarcoma cell line, U2OS, has a more robust tran-
scriptional response to Wnt-3A than HEK293T cells (unpub-
lished data). Therefore, we also tested whether MIB1 and RYK 
were required for Wnt/CTNNB1 signaling in U2OS cells. First, 
we confirmed that siRNAs targeting either RYK or MIB1 were 
able to reduce Wnt-3A–mediated activation of BAR in U2OS 
cells (Fig. 6 C). Likewise, we found that Wnt-3A increased   
levels of AXIN2 transcript more than fourfold in the context of 
control siRNAs and that this effect was significantly reduced by 
siRNAs targeting either RYK or MIB1 (Fig. 6 D). The expres-
sion of another Wnt-target gene, NKD1, was also reduced by 
RYK and MIB1 loss of function in U2OS cells (Fig. 6 E).   
Finally, we confirmed this effect in a third cell line. As with 
HEK293T  and  U2OS,  HeLa  cells  also  showed  reduced  re-
sponses  to  expression  of  the  Wnt-3A–induced  target  genes 
AXIN2, NKD1, and TNFRSF19 after RYK or MIB1 loss of 
function (Figs. 6 F and S2, E and F). In summary, these results 
demonstrate that endogenous RYK and MIB1 are required for 
Wnt/CTNNB1-dependent transcription in multiple cell lines.
MIB1 and RYK act upstream  
of CTNNB1 stabilization
Our data suggest that MIB1 regulates RYK by inhibiting its local-
ization at the cell surface. Thus, RYK and MIB1 loss of function 
could inhibit activation of Wnt/CTNNB1 signaling by affecting 
other components of the signaling pathway that operate near the 
plasma membrane. We found that siRNAs targeting either RYK 
or MIB1 inhibited the activation of BAR in cells overexpressing 
Wnt-3A or Disheveled 3 but had little effect on BAR activation 
by CTNNB1 or stabilized mutant CTNNB1 (CTNNB1*; S33A, 
S37A, T41A, and S45A; Fig. 7 A). Thus, RYK and MIB1 likely 
regulate events that occur early in Wnt pathway activation.
To further investigate the temporal requirement for MIB1 
in Wnt signaling, we performed a time-course analysis of 
HEK293T cells treated with Wnt-3A. We found that cells trans-
fected with MIB1 siRNA show reduced levels of phospho-LRP6, 
an early marker of Wnt activation, within 30 min of Wnt-3A 
treatment (Fig. 7 B; Davidson et al., 2005; Zeng et al., 2005). 
MIB1 loss of function inhibited the ability of Wnt-3A to reduce 
serine/threonine  phosphorylation  of  CTNNB1;  however,  we 
did  not  see  robust  changes  in  Wnt-3A–induced  steady-state   
levels of total CTNNB1 with MIB1 siRNA (Fig. 7 B).
vesicles (Fig. 4 A and Fig. S2 A). However, when RYK was 
coexpressed  with  flag-MIB1,  both  proteins  colocalized  on   
large intracellular membrane and vesicular organelles (Fig. 4,   
B and E; and Fig. S2 B). Notably, these organelles were also 
positive for the endocytic marker Rab5 (Fig. 4 B; Sorkin and   
von Zastrow, 2009).
Because MIB1 ubiquitinates RYK, we also asked whether 
the enzymatic activity of MIB1 was required for the relocal-
ization  of  RYK.  Co-expression  of  MIB1-C997S  with  RYK   
resulted in colocalization in protein aggregates or aggregated 
vesicles near the plasma membrane and in intracellular vesicles 
(Fig. 4, C and E; and Fig. S2 C). As with wild-type MIB1, 
these structures were also positive for Rab5. Although MIB1-
C997S has reduced enzymatic activity, residual ubiquitination 
of RYK (Fig. 2 A) could account for this change in RYK local-
ization. Thus, we also tested the enzyme-dead MIB1, MIB1-
RN3. Unlike MIB1 or MIB1-C997S, MIB1-RN3 had no effect 
on RYK localization, though both proteins colocalized at sites 
along the plasma membrane (Fig. 4, D and E; and Fig. S2 D).
MIB1 quantitatively reduces RYK  
surface expression in the absence  
of protein degradation
We next used an independent method to quantify surface RYK 
expression on individual cells. As we had found that MIB1 regu-
lates RYK protein turnover, MIB1-mediated decreases in total 
RYK might account for the loss of surface expression of RYK. 
Moreover, although the images were scored blind, immuno-
cytochemistry is inherently qualitative and subjective. Therefore,   
we used flow cytometry to quantify the intensity of RYK sur-
face expression in the context of proteasome and lysosome in-
hibition. HEK293T cells expressing glue-RYK were treated with 
chloroquine and MG132 for 2 h and then fixed in paraformalde-
hyde. We then used immunofluorescence under nonpermeabiliz-
ing conditions to detect the N-terminal glue epitope of RYK   
(Fig. 5 A). Using this method, we found that overexpression of 
MIB1 decreased the surface expression of RYK by >40% as 
compared with the vector-only control (Fig. 5, B and C). Ex-
pression of MIB1-C997S and MIB1-RN3 had little effect on 
RYK surface expression (Fig. 5, B and C). Moreover, as pre-
dicted from the fact that MIB1 does not ubiquitinate RYKICD 
(Fig. 2 A), we found that MIB1 overexpression did not change 
RYKICD surface expression compared with the vector-only 
control (Fig. 5 D).
We also tested whether endogenous MIB1 regulates sur-
face expression of RYK. As expected, the inhibition of MIB1 
expression by siRNA transfection increased surface RYK ex-
pression (Fig. 5, E and F). Collectively, these results suggest 
that MIB1 is both necessary and sufficient for the expression of 
RYK at the plasma membrane.
RYK and MIB1 are required for Wnt/
CTNNB1 signaling
Because  RYK  is  required  for  Wnt/CTNNB1  signaling  (Lu 
et al., 2004), we hypothesized that MIB1 might also regu-
late Wnt signaling. We measured the activity of a luciferase-
based transcriptional reporter (CTNNB1-activated reporter or   JCB • VOLUME 194 • NUMBER 5 • 2011   744
MIB1 activates Wnt/CTNNB1 signaling in 
an RYK-dependent manner
Collectively, our data suggest that RYK and MIB1 act together 
in a complex to regulate Wnt/CTNNB1 signaling. To directly test 
this model, we first asked whether MIB1 overexpression was suf-
ficient to activate Wnt signaling. Indeed, overexpression of MIB1 
activated BAR in a dose-dependent manner in the presence or ab-
sence of Wnt-3A (Fig. 8 A). Moreover, we found that MIB1 was 
sufficient to induce AXIN2 transcription, the phosphorylation of 
LRP6, and stabilization of CTNNB1 (Figs. 8, B and C). Second, 
if MIB1 and RYK act in a protein complex, then MIB1 might   
require interaction with RYK to activate Wnt/CTNNB1 signaling. 
We found that, unlike full-length MIB1, N-terminally truncated 
MIB1 mutants, e.g., aa 125–1,007, which do not form a complex 
with RYK (Fig. 1 C), cannot activate BAR (Fig. 8 D). Moreover, 
we found that MIB1 mutants, which can form a complex with 
HEK293T cells have high levels of membrane-associated 
CTNNB1, and levels of CTNNB1 are not appreciably changed 
by Wnt-3A treatment. Therefore, we also blotted for CTNNB1 
in the lysates that had been stripped of junctional CTNNB1 
using conA-sepharose resin (Miller and Moon, 1997). Using 
this  approach,  we  found  that  RYK  and  to  a  lesser  degree 
MIB1 siRNAs reduced the ability of Wnt-3A to increase   
the “signaling pool” of CTNNB1 after 1 h of treatment with 
Wnt-3A  (Fig.  7  C).  Like  our  results  in  HEK293T  cells,   
we found that the transfection of RYK or MIB1 siRNAs re-
duced the ability of Wnt-3A to increase LRP6 phosphorylation, 
reduce  CTNNB1  phosphorylation,  and  stabilize  CTNNB1   
in U2OS cells (Fig. 7 D). Collectively, our data show that 
RYK  and  MIB1  are  required  for  Wnt/CTNNB1  signaling 
through regulation of protein phosphorylation upstream of 
CTNNB1 stabilization.
Figure  5.  MIB1  quantitatively  reduces  RYK 
surface  expression  in  the  absence  of  protein 
degradation. (A, B, D, and E) Histograms of 
individual  cell  fluorescence  intensities  depict-
ing the distribution of surface labeling of RYK   
in  nonpermeabilized  HEK293T  cells  treated 
for 2 h with chloroquine and MG132, labeled, 
and  then  analyzed  by  flow  cytometry.   
(A) Histogram shows the background of anti-HA   
immunoreactivity in vector only as compared with 
glue-RYK–transfected  cells.  Background  inten-
sity was used to determine the RYK-positive gate 
in each experiment individually. (B) Histogram 
of surface RYK expression on cells transfected 
with glue-RYK and vector only or flag-MIB1 or 
flag-MIB1  mutants.  (C)  Graph  represents  the 
number of cells in the RYK-positive gate shown 
in B. Data demonstrate a significant decrease 
in surface RYK expression when cotransfected 
with MIB1 but not MIB1-C997S or MIB1-RN3. 
Data are mean + SD (error bars). *, P < 0.05. 
(Student’s t test, n = 3). (D) Histogram of sur-
face RYK expression on cells transfected with 
N-terminal glue-tagged RYKICD and with or 
without flag-MIB1. (E) Histogram of surface RYK 
expression  on  cells  transfected  with  glue-RYK 
and control, MIB1, or RYK siRNAs. (F) Graph 
representing  the  number  of  cells  in  the  RYK-
positive gate shown in E. Data demonstrate that 
MIB1 loss of function significantly increases the 
level of RYK expression on the cell surface. Data 
are mean + SD (error bars). **, P < 0.005. 
(Student’s t test, n = 3).745 MIB1 is required for Wnt/RYK signaling • Berndt et al.
resulting in a bivulva phenotype. Thus, we asked whether MIB1 
was also important in this process. First, we performed BLASTp 
analysis to identify the C. elegans homologue of human MIB1. 
We identified the protein, Q9U2C5, in the UniProt database.   
Using reverse BLASTp analysis, we found that Q9U2C5 has equal 
identity with human MIB1 and MIB2 (23%), which is consistent 
with the existence of a single ancestral protein (Fig. 9 A). Similar 
to human MIB1 and MIB2, Q9U2C5 contains seven predicted 
Ankyrin repeats and two C-terminal ring fingers. The gene encod-
ing Q9U2C5, Y47D3A.22, has predicted genetic interactions with 
several members of the Notch pathway, including crb-1/Crumbs, 
glp-1/Notch, F10D7.5/Neuralized, and lin-12/Notch, which sug-
gests conservation of function with human MIB1 and MIB2 in 
Delta/Notch signaling (Zhong and Sternberg, 2006). Therefore, 
we reasoned that Q9U2C5/Y47D3A.22, henceforth ceMIB, could 
be a functional homologue of human MIB1.
We  next  turned  to  loss  of  function  in  vivo  to  assess 
whether ceMIB was important for vulva cell fate determination. 
We found that RNAi targeting ceMIB resulted in 24% of worms 
with the bivulva phenotype (Fig. 9, B and E), which suggests 
that ceMIB, as with lin-18/RYK, is important for p7.p orienta-
tion. Mutations in lin-12/Notch also disrupt vulva development 
RYK but lack enzymatic activity toward RYK, e.g., C997S or 
RN3 (Figs. 1 C and 2 A), also failed to activate BAR (Fig. 8,   
A and D). Third and most importantly, if RYK and MIB1 act in the 
same molecular complex leading to activation of Wnt/CTNNB1 
signaling, then the inhibition of RYK expression should reduce 
the ability of MIB1 overexpression to activate BAR. In fact, we 
found that RYK siRNA transfection significantly inhibited the 
ability of MIB1 to activate BAR (Fig. 8 E). Thus, MIB1-induced 
activation of Wnt/CTNNB1 signaling requires the presence and 
binding of endogenous RYK. Moreover, these data show that 
MIB1 enzymatic activity is required to activate Wnt signaling. 
Whether the ubiquitination of RYK by MIB1 is required for 
Wnt activation remains an open question. However, these data 
strongly support a model in which endogenous RYK and enzy-
matically active MIB1 form a complex that has the ability to ac-
tivate or enhance Wnt/CTNNB1 signaling.
C. elegans MIB1 RNAi genetically interacts 
with lin-18/RYK
Wnt signaling is required for vulva cell fate determination in   
C. elegans (Inoue et al., 2004). Mutations of lin-18/RYK disrupt 
the oriented division of p7.p vulval precursor cells, ultimately 
Figure 6.  Endogenous RYK and MIB1 are required for Wnt/CTNNB1 signaling. (A and C) Graphs showing results from a Wnt/CTNNB1-activated   
luciferase-based reporter (BAR). Data are mean + SD (error bars). (B and D–F) Quantitative RT-PCR data showing a requirement for RYK and MIB1 in the 
expression of Wnt target genes in multiple cell lines. Data are mean + SD (error bars). (A) HEK293T cells were transfected with siRNAs for 2 d and then 
treated overnight with control or Wnt-3A–conditioned media. Results are normalized to one for unstimulated cells. Multiple nonoverlapping siRNAs target-
ing either RYK or MIB1 significantly reduce Wnt-3A–mediated reporter activation. Data are representative of n > 5 experiments. (B) Increases in AXIN2 
mRNA levels resulting from treatment with Wnt-3A–conditioned media are reduced in the context of MIB1 or RYK siRNA transfection in HEK293T cells.   
(C) Graph showing that MIB1 and RYK are required for Wnt-3A–mediated activation of BAR in U2OS cells treated as in A. n = 5. (D, E, and F) Graphs 
showing the results of quantitative RTPCR for AXIN2 (D and F) and NKD1 (E), demonstrating a requirement for MIB1 and RYK for the activation of endog-
enous Wnt-target genes by Wnt-3a in U2OS and HeLa cells. n = 3.JCB • VOLUME 194 • NUMBER 5 • 2011   746
MIB1 overexpression activates Wnt/CTNNB1 signaling in an 
RYK-dependent manner and that endogenous RYK and MIB1 
were  required  for  the  Wnt-dependent  activation  of  Wnt/
CTNNB1 signaling. Finally, we discovered that lin-18/RYK and 
ceMIB show a genetic interaction in C. elegans vulva develop-
ment. These findings raise several interesting questions sur-
rounding the relationship of RYK and MIB1 to Wnt signaling.
Does MIB1 regulate RYK trafficking in response to Wnt? 
Recent studies demonstrate that RYK undergoes endocytosis in 
response to Wnt binding in vivo (Kim et al., 2008; Lin et al., 
2010). We found that MIB1 regulated surface expression of 
RYK. However, we were unable to detect changes in the sur-
face localization of RYK after treatment with Wnt-3A in our 
system (unpublished data). Thus, we could not test whether 
MIB1 was required for Wnt-induced changes in RYK surface 
expression. Nevertheless, it remains formally possible that MIB1 
regulates the endocytosis of RYK after ligand binding.
What is the significance of MIB1-associated RYK ubiqui-
tination? The ubiquitination of transmembrane proteins can lead   
to endocytosis and trafficking to a variety of intracellular 
(Greenwald et al., 1983). Therefore, we performed experiments 
to assess the genetic interaction between ceMIB and lin-18/
RYK. Importantly, we found that ceMIB RNAi enhanced the 
penetrance of the bivulva phenotype in the lin-18/RYK(e620) 
mutant (Fig. 9, B and F). Collectively, although these results 
cannot rule out the possibility that MIB could regulate both Wnt 
and Notch signaling in vulva development, they do support a 
role for ceMIB in the regulation of C. elegans Wnt/RYK/TCF 
signaling and imply that the role of RYK and MIB1 in Wnt sig-
naling is conserved in vivo and across diverse animal phyla.
Discussion
Our goal was to investigate novel mechanisms involved in the 
regulation of Wnt/RYK signaling. We identified MIB1 as a 
novel  protein  interaction  partner  with  RYK.  We  found  that 
overexpressed RYK and MIB1 colocalized and that the over-
expression of MIB1 leads to the loss of surface RYK expression.   
In addition, biochemical studies revealed that MIB1 promotes 
the  ubiquitination  and  degradation  of  RYK.  We  found  that 
Figure 7.  Endogenous RYK and MIB1 are required for Wnt/CTNNB1 signaling at the level of receptor activation. (A) RYK and MIB1 siRNA transfection 
inhibits cDNA overexpression-mediated activation of BAR by Wnt-3A and Disheveled (DVL3) but not CTNNB1 or nondegradable CTNNB1* (S33A, S37A, 
T41A, and S45A). Data are mean + SD (error bars). (B) Western blot of cell lysates after a time course of treatment with Wnt-3A–conditioned media in 
cells transfected with control or MIB1 siRNAs. (C) Western blot after 1 h of treatment with Wnt-3A–conditioned media in HEK293T cells transfected with the 
indicated siRNAs. In rows labeled conA, cell lysates were stripped of membrane-associated proteins by overnight incubation with conA Sepharose resin. 
(D) Western blot after 1-h treatment with Wnt-3A–conditioned media in U2OS cells transfected with the indicated siRNAs. Blots represent n = 3.747 MIB1 is required for Wnt/RYK signaling • Berndt et al.
MIB1 ubiquitination of RYK signals the endocytosis of a mul-
timeric complex composed of RYK and other Wnt receptors. 
The endocytosis of LRP6 and Frizzled has been shown to be   
required  for  efficient  activation  of  Wnt/CTNNB1  signaling 
(Yamamoto et al., 2006; Yamamoto et al., 2008). Consistent 
with this model, we found that the knockdown of RYK or MIB1 
leads to reduced LRP6 phosphorylation and levels in response 
to Wnt. Whether MIB1 directly regulates the kinases neces-
sary for LRP6 phosphorylation is unknown.
A second possibility is that MIB1 acts downstream of 
RYK. In this model, the ubiquitination/degradation of RYK 
could reflect a negative feedback loop regulating RYK surface 
expression. The kinase MARK (microtubule affinity regulating 
kinase)/PAR1 can phosphorylate and modulate the function of 
MIB1 (Ossipova et al., 2009). PAR1 is also known to bind the 
membrane-associated  Wnt  pathway  protein  Disheveled  (Sun   
et al., 2001). Thus, Wnt signaling through RYK could modulate 
PAR1 phosphorylation of MIB1 and its subsequent activity on 
organelles (Sorkin and von Zastrow, 2009). We observed that 
overexpressed MIB1 promotes the ubiquitination of RYK and 
loss of surface expression. MIB1 also promotes the ubiquitination 
and endocytosis of the Notch ligand, Delta (Itoh et al., 2003). 
Ubiquitination of Delta by MIB1 is thought to promote trafficking 
through the recycling endosome and further maturation by post-
translational modification (Itoh et al., 2003; Hamel et al., 2010). 
Our biochemical data suggest that MIB1 promotes RYK degra-
dation by the lysosome. However, our experiments do not rule 
out the possibility that physiological levels of MIB1 alter the sub-
cellular trafficking of RYK in the absence of RYK degradation.
How does MIB1 activate Wnt/CTNNB1 signaling? RYK 
is required for Wnt/CTNNB1 signaling both in vitro and in vivo 
(Lu et al., 2004; Inoue et al., 2004; Deshpande et al., 2005;   
Lyu et al., 2008; this paper). Likewise, we found that MIB1 loss 
of function inhibits Wnt/CTNNB1 signaling. Paradoxically, we 
also showed that MIB1 overexpression activates Wnt signal-
ing  yet  degrades  RYK.  One  possible  explanation  is  that 
Figure 8.  MIB1 requires endogenous RYK to activate Wnt/CTNNB1 signaling. (A) Graph demonstrating that MIB1 cDNA overexpression but not catalyti-
cally impaired MIB1-C997S can activate BAR in the presence or absence of Wnt-3A–conditioned media. Cells were transfected 6–8 h before treatment 
with conditioned media overnight. Data are mean + SD. n = 3. (B) Data generated from quantitative RT-PCR or HEK293T cells overexpressing MIB1 show-
ing activation of the Wnt target gene, AXIN2. Data are mean + SD (error bars). *, P < 0.05 using a Student’s t test. n = 3. (C) Western blot of HEK293T 
cells overexpressing MIB1 showing that MIB1 can activate LRP6 phosphorylation and stimulate CTNNB1 stabilization. In rows labeled conA, cell lysates 
were stripped of membrane-associated proteins by overnight incubation with conA Sepharose resin. Blot represents n = 3. (D) Data showing the enhance-
ment of Wnt-3A–induced BAR activity by the overexpression of MIB1 but not by mutants of MIB1 that lack the ability to bind RYK or lack enzymatic activity. 
The dotted line indicates the level of reporter activation by Wnt-3A–conditioned media alone. Data are mean + SD (error bars). n = 3. (E) Data demonstrat-
ing that MIB1-mediated activation of BAR is reversed by multiple independent siRNAs targeting either CTNNB1 or RYK. The dotted line indicates the level 
of reporter activation by MIB1 overexpression alone. Data are mean + SD (error bar). n = 3.JCB • VOLUME 194 • NUMBER 5 • 2011   748
the tools at the National Center for Biotechnology Information and UniProt 
databases. Phylogenetic analysis was performed with ClustalW2 using the 
neighbor joining method. Full-length Y47D3A.22/ceMIB was amplified 
from a pool of cDNA from mixed stage wild-type (N2) worms and cloned 
into the L4440 vector for RNAi feeding. To minimize the maternal contribu-
tion, worms were fed on RNAi plates for more than two generations before 
scoring. Live L4 stage larvae were mounted in PBS on glass slides. Differen-
tial interference contrast images were collected at room temperature using 
NIS Elements software and a Plan Fluor 40×/0.90 NA objective lens on 
an inverted wide-field microscope (TiE; Nikon). Scores represent the sum 
of three individual experiments.
Molecular cloning
RYK  was  amplified  by  PCR  (GenBank/EMBL/DDBJ  accession  no.  NM_
001005861, base pairs 229–1923) from human fetal cDNA and cloned 
into a modified pGLUE vector (Angers et al., 2006) using Asc1 and Not1. 
The signal sequence from CHRNA7 was added 5 to the streptavidin-binding 
peptide  in  the  glue  tag  (5-ATGCGGTGCAGCCCCGGCGGCGTGTG-
GCTGGGCCTGGCCGCCTCTCTGCTTCATGTGAGCCTG-3). RYK lacking 
the ICD (base pairs 229–882) was amplified by PCR and cloned into signal 
sequence pGLUE using AscI and NotI. The ICD of RYK was amplified by PCR 
(base pairs 883–1923) and cloned into pGLUE using AscI and NotI. MYR-
GLUE-RYKICD was made by appending the myristoylation sequence of SRC 
(5-ATGGGTAGCAACAAGAGCAAGCCCAAGGAT-3) 5 to the strepta-
vidin-binding peptide in pGLUE-RYKICD. mRYK clones were received from   
W. Lu (University of Southern California, Los Angeles, CA). All other cDNA 
clones were generated by standard PCR-based cloning. Whole-plasmid PCR 
was used for site-directed mutagenesis of MIB1. All clones were verified by 
complete sequencing of the open reading frames.
Quantitative RT-PCR
RNA was extracted using the RNAeasy RNA extraction kit as per the manu-
facturer’s recommendations (QIAGEN). First-strand cDNA was synthesized 
using oligodeoxythymidine and random hexamer primers with the Revert-
aid kit (Fermentas). Quantitative RT-PCR was performed on a LightCycler 
480 using 10 µl reactions (Roche). Primers used are listed in Table S2.
Immunocytochemistry, immunoprecipitation, and Western blotting
For  immunocytochemistry,  cells  were  seeded  onto  poly-d-lysine  (Sigma- 
Aldrich)-coated coverslips and fixed in 4% paraformaldehyde in PBS at 
22°C for 10 min. For overexpression studies, cells were transfected with 
100 ng/cm
2 of plasmid 18–20 h before fixation. Secondary antibodies 
an  unknown  effector  of  Wnt  signaling.  Further  studies  are 
needed to assess the biochemical relationships of MIB1, RYK, 
and other members of the Wnt pathway, and the requirement of 
MIB1 and RYK for Wnt-mediated changes in protein com-
plexes, posttranslational modification, and localization should 
help clarify these issues.
In conclusion, we demonstrated the first evidence that the 
ubiquitin ligase MIB1 acts to regulate Wnt/CTNNB1 signaling 
in a complex with the Wnt receptor RYK. MIB1 is an important 
regulator of multiple developmental phenomena, many of which 
are known to require Wnt signaling. Moreover, because MIB1 
acts in other signal transduction pathways, such as Delta/Notch, 
it represents a novel node for mitigating pathway cross-talk. In 
the future, it will be important evaluate developmental and dis-
ease phenotypes resulting from MIB1 mutation or deletion in 
the context of both Notch and Wnt signaling.
Materials and methods
Cell culture, transfections, and drugs
Hela, HEK293T, and U2OS cells were obtained from the American Type 
Culture Collection and cultured in DME plus 10% FBS and 1% penicil-
lin/streptomycin  (Invitrogen).  siRNA  transfections  were  performed  with 
Lipofectamine RNAiMAX (Invitrogen). siRNAs were used singly or in equi-
molar pools at 20 nM total concentration. siRNA sequences are given in 
Table S1. cDNA transfections were performed with Lipofectamine 2000 
(HEK293T; Invitrogen) or Fugene HD (HeLa; Roche). For protein turnover 
studies, cells were treated overnight with 10 µM DAPT or 1 µM L-685,485 
(both from Tocris Bioscience) or for the indicated times with 10 µg/ml 
cycloheximide (Sigma-Aldrich), 100 µM chloroquine (Sigma-Aldrich), or 
10 µM MG132 (EMD).
C. elegans maintenance and RNAi
Wild-type(N2) and lin-18(e620) strains were gifts from the Priess labora-
tory (Fred Hutchinson Cancer Research Center, Seattle, WA). To identify 
the C. elegans homologue of MIB1, we performed BLASTp analyses using 
Figure 9.  C. elegans MIB1 RNAi genetically interacts with 
lin-18/RYK. (A) Phylogram representing the relationship of 
ceMIB to the top four hits from a BLASTp analysis of the   
human proteome. (B) Quantification of the bivulva phenotype 
from three independent RNAi feeding experiments. *, P < 
0.0001; #, P < 0.05, Fisher’s exact test. (C–F) Images of L4 
stage C. elegans larvae. ceMIB RNAi, mutation in lin-18/ 
RYK, or the combination of both results in the bivulva phe-
notype characteristic of abnormal vulva cell fate specifica-
tion. Anterior is to the left and dorsal is up. Arrowheads 
indicate vulval invaginations. Bar, 10 µm.749 MIB1 is required for Wnt/RYK signaling • Berndt et al.
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coupled to a Nikon A1R confocal operating in Galvano mode and using a 
Plan-Apochromat 60×/1.40 NA oil objective lens (Nikon). Quantification 
was performed by an observer that was blinded to the treatments. Images 
were processed for publication using GIMP 2.6.8 and Inkscape 0.47.
For immunoprecipitation and Western blotting, cells were lysed in 
50 mM Tris, pH 8.0, 1% Triton X-100, 0.1% SDS, 0.2% sodium deoxycho-
late, 150 mM sodium chloride, and 2 mM EDTA plus complete protease 
and phosphatase inhibitors (Roche). Affinity purification was performed for 
2–4 h at 4°C with streptavidin-Sepharose (GE Healthcare) or anti-flag M2 
affinity gel (Sigma-Aldrich). For metal affinity purification cells, were lysed 
in 6 M urea, 300 mM sodium chloride, and 10 mM imidazole in 100 mM 
sodium phosphate buffer, pH 7.4, and purified 2–4 h at 22°C with Ni-NTA 
agarose (QIAGEN). The His-tagged ubiquitin plasmid was a gift from D. 
Bohmann (University of Rochester, Rochester, NY).
Primary antibodies used were CTNNB1 (9561 and 9562; Cell Sig-
naling Technology), -tubulin (T7816; Sigma-Aldrich), flag (F3165 and 
F7425; Sigma-Aldrich), HA (3F10, 1867423; Roche), LRP6 (2568 and 
3395; Cell Signaling Technology), MIB1 (M5948; Sigma-Aldrich), Rab5 
(SC-28570; Santa Cruz Biotechnology, Inc.), TSG101 (Ab83; Abcam), 
and ubiquitin (P4D1, SC-8017; Santa Cruz Biotechnology, Inc.).
Surface labeling and flow cytometric analysis
Cells were treated for 2 h with 100 µM chloroquine and 10 µM MG132, 
harvested by trituration, and fixed for 10 min in 1% paraformaldehyde in 
PBS. N-terminal glue-tagged proteins were detected with an HA antibody 
for 2 h at room temperature followed by donkey anti–rat Alexa Fluor 488 
for 30 min under nonpermeabilization conditions. At least 10,000 events 
per sample were collected on a FACS Canto II flow cytometer (BD) and 
analyzed with FlowJo (Tree Star).
Affinity purification mass spectrometry and bioinformatics
Tandem affinity purification was performed essentially as described previ-
ously (Angers et al., 2006; Major et al., 2007; Major et al., 2008). In 
brief, cell lysates from 15 × 15 cm plates of HEK293T cells were subjected 
to affinity purification with streptavidin-Sepharose (GE Healthcare). Bound 
protein complexes were eluted with 50 mM biotin and further purified with 
calmodulin Sepharose 4B (GE Healthcare). After elution with EGTA, pro-
teins were reduced and alkylated and then trypsinized overnight at 37°C 
(Promega). Tryptic peptides were separated by reverse phase nano-HPLC 
(Eksigent) and eluted directly into a LTQ-XL mass spectrometer (Thermo-
Fisher Scientific). Resultant spectra were searched using Sequest and the 
Transproteomic Pipeline on a Sorcerer2 (Sage N Research). Unfiltered pro-
tein datasets are provided in Table S3. After compiling and filtering the 
data, proteins were submitted to the Search Tool for the Retrieval of Inter-
acting Genes/Proteins (STRING) database to curate known interactions 
(von Mering et al., 2003). The protein list was also queried on the Data-
base for Annotation, Visualization and Integrated Discovery (DAVID) func-
tional annotation clustering platform to identify protein complex functions 
(Dennis et al., 2003). Protein interaction networks were created with Cyto-
scape 2.7.0 (Shannon et al., 2003).
Online supplemental material
Fig. S1 shows that RYK and MIB1 siRNAs efficiently knock down mRNA 
and protein. Fig. S2 shows that MIB1 inhibits surface localization of RYK 
and is required for Wnt/CTNNB1 signaling in Hela cells. Table S1 shows 
siRNA. Table S2 shows quantitative RT-PCR primer sequences. Table S3 
shows proteomics data and conditions. Table S4 shows DAVID functional 
annotation of proteomics hits. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201107021/DC1.
We would like to thank T. Biechele, J. Boyd, W. Conrad, P. von Haller, 
M. B. Major, M. MacCoss, R. Seifert, and A. Zhou for technical assistance 
and advice.
J.D. Berndt is an associate and R.T. Moon is an investigator of the 
Howard Hughes Medical Institute. Salary for P. Yang was funded by the Rubicon 
grant  from  Netherlands  Organization  for  Scientific  Research  (NWO; 
825.08.020). We thank the Lynn and Mike Garvey Cell Imaging Laboratory 
for providing instrumentation and support for imaging.
Submitted: 4 July 2011
Accepted: 2 August 2011JCB • VOLUME 194 • NUMBER 5 • 2011   750
phosphorylation  and  activation.  Nature.  438:873–877.  doi:10.1038/ 
nature04185
Zhang, C., Q. Li, and Y.-J. Jiang. 2007. Zebrafish Mib and Mib2 are mutual E3 
ubiquitin ligases with common and specific delta substrates. J. Mol. Biol. 
366:1115–1128. doi:10.1016/j.jmb.2006.11.096
Zhong, W., and P.W. Sternberg. 2006. Genome-wide prediction of C. elegans 
genetic  interactions.  Science.  311:1481–1484.  doi:10.1126/science 
.1123287
of corticospinal tract. Nat. Neurosci. 8:1151–1159. (published erratum 
appears in Nat. Neurosci. 2006. 9:147)  doi:10.1038/nn1520
Logan, C.Y., and R. Nusse. 2004. The Wnt signaling pathway in develop-
ment and disease. Annu. Rev. Cell Dev. Biol. 20:781–810. doi:10.1146/ 
annurev.cellbio.20.010403.113126
Lu, W., V. Yamamoto, B. Ortega, and D. Baltimore. 2004. Mammalian Ryk 
is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell. 
119:97–108. doi:10.1016/j.cell.2004.09.019
Lyu, J., V. Yamamoto, and W. Lu. 2008. Cleavage of the Wnt receptor Ryk 
regulates neuronal differentiation during cortical neurogenesis. Dev. Cell. 
15:773–780. doi:10.1016/j.devcel.2008.10.004
Lyu, J., R.L. Wesselschmidt, and W. Lu. 2009. Cdc37 regulates Ryk signal-
ing by stabilizing the cleaved Ryk intracellular domain. J. Biol. Chem. 
284:12940–12948. doi:10.1074/jbc.M900207200
Major, M.B., N.D. Camp, J.D. Berndt, X. Yi, S.J. Goldenberg, C. Hubbert, T.L. 
Biechele, A.-C. Gingras, N. Zheng, M.J. Maccoss, et al. 2007. Wilms   
tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. 
Science. 316:1043–1046. doi:10.1126/science/1141515
Major, M.B., B.S. Roberts, J.D. Berndt, S. Marine, J. Anastas, N. Chung, M. 
Ferrer, X. Yi, C.L. Stoick-Cooper, P.D. von Haller, et al. 2008. New regu-
lators of Wnt/beta-catenin signaling revealed by integrative molecular 
screening. Sci. Signal. 1:ra12. doi:10.1126/scisignal.2000037
Miller, J.R., and R.T. Moon. 1997. Analysis of the signaling activities of local-
ization mutants of -catenin during axis specification in Xenopus. J. Cell 
Biol. 139:229–243. doi:10.1083/jcb.139.1.229
Miyashita, T., M. Koda, K. Kitajo, M. Yamazaki, K. Takahashi, A. Kikuchi, and 
T. Yamashita. 2009. Wnt-Ryk signaling mediates axon growth inhibition 
and limits functional recovery after spinal cord injury. J. Neurotrauma. 
26:955–964. doi:10.1089/neu.2008.0776
Moon, R.T., A.D. Kohn, G.V. De Ferrari, and A. Kaykas. 2004. WNT and beta-
catenin signalling: diseases and therapies. Nat. Rev. Genet. 5:691–701. 
doi:10.1038/nrg1427
Ossipova,  O.,  J.  Ezan,  and  S.Y.  Sokol.  2009.  PAR-1  phosphorylates  Mind 
bomb  to  promote  vertebrate  neurogenesis.  Dev.  Cell.  17:222–233. 
doi:10.1016/j.devcel.2009.06.010
Raiborg, C., and H. Stenmark. 2009. The ESCRT machinery in endosomal sorting 
of ubiquitylated membrane proteins. Nature. 458:445–452. doi:10.1038/ 
nature07961
Schmitt, A.M., J. Shi, A.M. Wolf, C.-C. Lu, L.A. King, and Y. Zou. 2006. Wnt-
Ryk signalling mediates medial-lateral retinotectal topographic mapping. 
Nature. 439:31–37.
Shannon, P., A. Markiel, O. Ozier, N.S. Baliga, J.T. Wang, D. Ramage, N. Amin, 
B. Schwikowski, and T. Ideker. 2003. Cytoscape: a software environment 
for integrated models of biomolecular interaction networks. Genome Res. 
13:2498–2504. doi:10.1101/gr.1239303
Sorkin, A., and M. von Zastrow. 2009. Endocytosis and signalling: intertwin-
ing molecular networks. Nat. Rev. Mol. Cell Biol. 10:609–622. doi:10 
.1038/nrm2748
Sun, T.Q., B. Lu, J.J. Feng, C. Reinhard, Y.N. Jan, W.J. Fantl, and L.T. 
Williams. 2001. PAR-1 is a Dishevelled-associated kinase and a posi-
tive regulator of Wnt signalling. Nat. Cell Biol. 3:628–636. doi:10.1038/ 
35083016
Trivier, E., and T.S. Ganesan. 2002. RYK, a catalytically inactive recep-
tor tyrosine kinase, associates with EphB2 and EphB3 but does not   
interact with AF-6. J. Biol. Chem. 277:23037–23043. doi:10.1074/jbc 
.M202486200
von Mering, C., M. Huynen, D. Jaeggi, S. Schmidt, P. Bork, and B. Snel. 2003. 
STRING: a database of predicted functional associations between pro-
teins. Nucleic Acids Res. 31:258–261. doi:10.1093/nar/gkg034
Wouda, R.R., M.R.K.S. Bansraj, A.W.M. de Jong, J.N. Noordermeer, and 
L.G. Fradkin. 2008. Src family kinases are required for WNT5 signal-
ing through the Derailed/RYK receptor in the Drosophila embryonic 
central nervous system. Development. 135:2277–2287. doi:10.1242/ 
dev.017319
Yamamoto, H., H. Komekado, and A. Kikuchi. 2006. Caveolin is necessary for 
Wnt-3a-dependent internalization of LRP6 and accumulation of beta-
catenin. Dev. Cell. 11:213–223. doi:10.1016/j.devcel.2006.07.003
Yamamoto, H., H. Sakane, H. Yamamoto, T. Michiue, and A. Kikuchi. 2008. 
Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to 
tune the activation of beta-catenin signaling. Dev. Cell. 15:37–48. doi:10 
.1016/j.devcel.2008.04.015
Yoo, K.-W., E.-H. Kim, S.-H. Jung, M. Rhee, B.-K. Koo, K.-J. Yoon, Y.-Y. 
Kong, and C.-H. Kim. 2006. Snx5, as a Mind bomb-binding protein, is 
expressed in hematopoietic and endothelial precursor cells in zebrafish. 
FEBS Lett. 580:4409–4416. doi:10.1016/j.febslet.2006.07.009
Zeng, X., K. Tamai, B. Doble, S. Li, H. Huang, R. Habas, H. Okamura, J. 
Woodgett, and X. He. 2005. A dual-kinase mechanism for Wnt co-receptor   